HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prolonged use of intravenous lipid emulsion in a severe tricyclic antidepressant overdose.

AbstractINTRODUCTION:
Intravenous lipid emulsion (ILE) resuscitation is now frequently being used for severe overdoses due to lipophilic drugs. However, the optimal dose, duration, and safety are still unclear.
CASE REPORT:
A patient with refractory cardiovascular collapse following an amitriptyline overdose was treated with ILE with initial improvement. Instability recurred after ILE discontinuation and lipid therapy was restarted, but high-dose treatment was complicated by severe lipemia. A low-dose infusion was instead used, and the patient did not experience further toxicity despite amitriptyline levels in the toxic range for 21 days. He survived to discharge without long-term sequelae.
DISCUSSION:
A low-dose infusion of ILE was well tolerated and may have successfully prevented recurrent toxicity in a case of severe tricyclic antidepressant overdose.
AuthorsRavi Agarwala, Syed Zaki Ahmed, Timothy J Wiegand
JournalJournal of medical toxicology : official journal of the American College of Medical Toxicology (J Med Toxicol) Vol. 10 Issue 2 Pg. 210-4 (Jun 2014) ISSN: 1937-6995 [Electronic] United States
PMID24173885 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antidepressive Agents, Tricyclic
  • Fat Emulsions, Intravenous
  • Amitriptyline
Topics
  • Adult
  • Amitriptyline (chemistry, poisoning)
  • Antidepressive Agents, Tricyclic (chemistry, poisoning)
  • Combined Modality Therapy (adverse effects)
  • Drug Overdose (physiopathology, therapy)
  • Fat Emulsions, Intravenous (adverse effects, therapeutic use)
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Hyperlipidemias (etiology, prevention & control)
  • Male
  • Recurrence
  • Severity of Illness Index
  • Shock (etiology, prevention & control)
  • Suicide, Attempted
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: